Methylphenidate in the Treatment of Children and Adolescents With Bipolar Disorder and Attention-Deficit/Hyperactivity Disorder
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Objective To examine the short-term efficacy of methylphenidate in the treatment of youths with bipolar disorder (BD) and comorbid attention deficit/hyperactivity disorder (ADHD). Method A 4-week double-blind, placebo-controlled trial in youths ages 5 to 17 years was conducted. Subjects met DSM-IV criteria for bipolar disorder and ADHD, were currently receiving a stable dose of at least one thymoleptic, and while euthymic continued to have clinically significant symptoms of ADHD. Patients received 1 week each of placebo, methylphenidate 5 mg twice daily, methylphenidate 10 mg twice daily, and methylphenidate 15 mg twice daily using a crossover design. Subjects were randomly assigned to receive one of six possible dosing orders. At study's end, and before the blind being broken, a "best dose week" for each subject was determined. The primary outcome measure was the total score on the parent-completed ADHD Rating Scale-IV. Results Sixteen patients, with a mean age of 10.43 (SD 3.14) years completed the trial. Lower scores during best dose treatment compared to the week of placebo treatment were found on the ADHD Rating Scale-IV (p Conclusions Euthymic youths with bipolar disorder and ADHD may benefit from short-term concomitant treatment with methylphenidate.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adjunctive mixed amphetamine salts (level 3)611 and methylphenidate (level 3)612 have both been shown to be effective in addressing attention symptoms and have been well tolerated overall within the RCTs completed to date,”
In the citing paper
“Mixed amphetamine salts (level 3),611 methylphenidate (level 3),612 atomoxetine (level 4),615 bupropion (level 4),766 or lisdexamfetamine (level 4)767 add‐ons to mood‐stabilizing treatments have been reported to be efficacious in improving ADHD symptoms.”
Citations
Cites
KAUFMAN, J., BIRMAHER, B., BRENT, D., RAO, U., FLYNN, C., MORECI, P., WILLIAMSON, D., & RYAN, N. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199707000-00021 · Cited by 10,148
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744
Norussis, H. (1993) · Medical Entomology and Zoology · Cited by 2,704
Meta-analysis of experiments with matched groups or repeated measures designs
Dunlap, W. P., Cortina, J. M., Vaslow, J. B., & Burke, M. J. (1996) · Psychological Methods · doi:10.1037/1082-989x.1.2.170 · Cited by 1,693
Greenhill, L. L., Pliszka, S., & Dulcan, M. K. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200202001-00003 · Cited by 927
Attention-Deficit Hyperactivity Disorder and Juvenile Mania: An Overlooked Comorbidity?
BIEDERMAN, J., FARAONE, S., MICK, E., WOZNIAK, J., CHEN, L., OUELLETTE, C., MARRS, A., MOORE, P., GARCIA, J., MENNIN, D., et al. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199608000-00010 · Cited by 389
Rapid, continuous cycling and psychiatric co-morbidity in pediatric bipolar I disorder
Findling, R. L., Gracious, B. L., McNamara, N. K., Youngstrom, E. A., Demeter, C. A., Branicky, L. A., & Calabrese, J. R. (2001) · Bipolar Disorders · doi:10.1034/j.1399-5618.2001.030405.x · Cited by 341
Self-citationGeller, B., Zimerman, B., Williams, M., DelBello, M. P., Bolhofner, K., Craney, J. L., Frazier, J., Beringer, L., & Nickelsburg, M. J. (2002) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/10445460252943533 · Cited by 322
Scheffer, R. E., Kowatch, R. A., Carmody, T., & Rush, A. J. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.1.58 · Cited by 260
Findling, R. L., Mcnamara, N. K., Youngstrom, E. A., Stansbrey, R., Gracious, B. L., Reed, M. D., & Calabrese, J. R. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000155981.83865.ea · Cited by 252
Self-citation
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Self-citationYatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Beaulieu, S., Alda, M., O’Donovan, C., MacQueen, G., McIntyre, R. S., Sharma, V., et al. (2013) · Bipolar Disorders · doi:10.1111/bdi.12025 · Cited by 1,217
Attention‐Deficit‐Hyperactivity Disorder: An Update
Dopheide, J. A., & Pliszka, S. R. (2009) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.6.656 · Cited by 645
Yatham, L. N., Kennedy, S. H., Schaffer, A., Parikh, S. V., Beaulieu, S., O'Donovan, C., MacQueen, G., McIntyre, R. S., Sharma, V., Ravindran, A., et al. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00672.x · Cited by 570
Self-citationMethylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
Storebø, O. J., Ramstad, E., Krogh, H. B., Nilausen, T. D., Skoog, M., Holmskov, M., Rosendal, S., Groth, C., Magnusson, F. L., Moreira-Maia, C. R., et al. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009885.pub2 · Cited by 347
Stiefel, G., & Besag, F. M. C. (2010) · Drug Safety · doi:10.2165/11536380-000000000-00000 · Cited by 257
Goldstein, B. I., Birmaher, B., Carlson, G. A., DelBello, M. P., Findling, R. L., Fristad, M., Kowatch, R. A., Miklowitz, D. J., Nery, F. G., Perez‐Algorta, G., et al. (2017) · Bipolar Disorders · doi:10.1111/bdi.12556 · Cited by 234
Self-citationThe vigilance regulation model of affective disorders and ADHD
Hegerl, U., & Hensch, T. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.10.008 · Cited by 212
Storebø, O. J., Krogh, H. B., Ramstad, E., Moreira-Maia, C. R., Holmskov, M., Skoog, M., Nilausen, T. D., Magnusson, F. L., Zwi, M., Gillies, D., et al. (2015) · BMJ · doi:10.1136/bmj.h5203 · Cited by 209
Developmental comorbidity in attention-deficit/hyperactivity disorder
Taurines, R., Schmitt, J., Renner, T., Conner, A. C., Warnke, A., & Romanos, M. (2010) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-010-0040-0 · Cited by 198
Waxmonsky, J., Pelham, W. E., Gnagy, E., Cummings, M. R., O'Connor, B., Majumdar, A., Verley, J., Hoffman, M. T., Massetti, G. A., Burrows-MacLean, L., et al. (2008) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2008.065 · Cited by 138
“The YMRS was selected as the mania symptom measure because it is the most commonly used efficacy scale in pediatric BP trials and reliably detects treatment effects (Carlson et al. 2003; Pavuluri et al. 2005; Scheffer et al. 2005; Findling et al. 2007).”
InfluentialBond, D. J., Hadjipavlou, G., Lam, R. W., McIntyre, R. S., Beaulieu, S., Schaffer, A., & Weiss, M. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400104 · Cited by 133
Pharmacologic Treatments for Pediatric Bipolar Disorder: A Review and Meta-Analysis
Liu, H. Y., Potter, M. P., Woodworth, K. Y., Yorks, D. M., Petty, C. R., Wozniak, J. R., Faraone, S. V., & Biederman, J. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2011.05.011 · Cited by 144
Awudu, G. A. H., & Besag, F. (2014) · Drug Safety · doi:10.1007/s40264-014-0201-8 · Cited by 125
The Risk of Treatment-Emergent Mania With Methylphenidate in Bipolar Disorder
Viktorin, A., Rydén, E., Thase, M. E., Chang, Z., Lundholm, C., D’Onofrio, B. M., Almqvist, C., Magnusson, P. K. E., Lichtenstein, P., Larsson, H., et al. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16040467 · Cited by 112
Comorbidity in pediatric bipolar disorder: Prevalence, clinical impact, etiology and treatment
Frías, Á., Palma, C., & Farriols, N. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.12.008 · Cited by 126
Geissler, J. M., Romanos, M., Hegerl, U., & Hensch, T. (2014) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-014-0144-z · Cited by 119
“2003; Kummer and Teixeira 2008) and three recent controlled trials (Findling et al. 2007; Scheffer et al. 2005; Zeni et al. 2009) showed that adding a stimulant did not worsen, but often improved manic symptomatology.”
BackgroundFaraone, S. V., Biederman, J., & Wozniak, J. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12010087 · Cited by 92
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
Storebø, O. J., Storm, M. R. O., Ribeiro, J. P., Skoog, M., Groth, C., Edemann-Callesen, H., Schaug, J. P., Rasmussen, P. D., Huus, C.-M. L., Zwi, M., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009885.pub3 · Cited by 163
Comorbidity in Pediatric Bipolar Disorder
Joshi, G., & Wilens, T. E. (2009) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2008.12.005 · Cited by 94
Zeni, C. P., Tramontina, S., Ketzer, C. R., Pheula, G. F., & Rohde, L. A. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2009.0037 · Cited by 85
“This strengthens the hypothesis that MPH may preferentially not precipitate or exacerbate manic or psychotic symptoms in patients treated with antimanic or antipsychotic agents (Carlson et al. 1992; Scheffer et al. 2005; Findling et al. 2007).”
InfluentialAtomoxetine acts as an NMDA receptor blocker in clinically relevant concentrations
Ludolph, A. G., Udvardi, P. T., Schaz, U., Henes, C., Adolph, O., Weigt, H. U., Fegert, J. M., Boeckers, T. M., & Föhr, K. J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00707.x · Cited by 82
“Memantine, an uncompetitive NMDA receptor antagonist used for the treatment of Alzheimer’s disease, was evaluated in an open-label pilot study for its effectiveness in paediatric patients with ADHD (Findling et al., 2007b).”
BackgroundMethodInfluentialAntidepressants and Psychostimulants in Pediatric Populations: Is there an Association with Mania?
Goldsmith, M., Singh, M., & Chang, K. (2011) · Pediatric Drugs · doi:10.2165/11591660-000000000-00000 · Cited by 79
“To address this concern, there have been three prospective trials examining the effects of psychostimulants when added to mood stabilizers in euthymic youth with BD for the treatment of co-morbid ADHD, and one prospective study of atomoxetine (table II).([16,19,21,23]) Three of the four studies demonstrated that the a…”
BackgroundMethodResultPost-Acute Effectiveness of Lithium in Pediatric Bipolar I Disorder
Findling, R. L., Kafantaris, V., Pavuluri, M. N., McNamara, N., Frazier, J. A., Sikich, L., Kowatch, R. A., Rowles, B. M., Clemons, T. E., & Taylor‐Zapata, P. (2013) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2012.0063 · Cited by 77
“Further, the addition of a stimulant to a mood stabilizer for the treatment of comorbid attention-deficit/hyperactivity disorder has demonstrated effectiveness in children and adolescents with bipolar disorder (Scheffer et al. 2005; Findling et al. 2007).”
BackgroundSelf-citationCortese, S., Bellgrove, M. A., Brikell, I., Franke, B., Goodman, D. W., Hartman, C. A., Larsson, H., LEVIN, F. R., Ostinelli, E. G., Parlatini, V., et al. (2025) · World Psychiatry · doi:10.1002/wps.21374 · Cited by 114
“…trial data have been supported by larger registry studies demonstrating the destabilizing tendency of stimulants over 6 months in adults with bipolar disorder not receiving mood stabilizing agents, whereas there was no manic activation when stimulants were combined with mood stabilizers 214 .”
Chang, K., Nayar, D., Howe, M., & Rana, M. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2009.0030 · Cited by 56
“Nonetheless, these findings suggest that in addition to stimulants (Scheffer et al. 2005; Findling et al. 2007), atomoxetine may offer another treatment option for ADHD co-morbid with BPD in children and adolescents.”
BackgroundSubstance-use disorders in adolescents and adults with ADHD: focus on treatment
Wilens, T. E., & Morrison, N. R. (2012) · Neuropsychiatry · doi:10.2217/npy.12.39 · Cited by 52
Use of Stimulants in Bipolar Disorder
Perugi, G., Vannucchi, G., Bedani, F., & Favaretto, E. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0758-x · Cited by 50
Pharmacotherapy of ADHD in Adults
Wilens, T. E. (2008) · CNS Spectrums · doi:10.1017/s1092852900002960 · Cited by 50
Pharmacotherapy of bipolar disorder in children and adolescents: an update
Peruzzolo, T. L., Tramontina, S., Rohde, L. A., & Zeni, C. (2013) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2012-0999 · Cited by 54
Psychopharmacology of Pediatric Bipolar Disorders in Children and Adolescents
Thomas, T., Stansifer, L., & Findling, R. L. (2011) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2010.10.001 · Cited by 46
Self-citationPharmacologic Treatment of Bipolar Disorder in Children and Adolescents
Goldstein, B. I., Sassi, R. B., & Diler, R. S. (2012) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2012.07.004 · Cited by 46
“A subsequent 4-week RCT of adjunctive methylphenidate versus placebo demonstrated a large ES for methylphenidate.(126) There were no systematic”
BackgroundRucklidge, J. J., Gately, D., & Kaplan, B. J. (2010) · BMC Psychiatry · doi:10.1186/1471-244x-10-74 · Cited by 41
“The response rate of the subsample of those with both ADHD and PBD symptoms is of particular relevance given the overall lack of response of this subgroup to conventional mood stabilizing medications, estimated between 20-29% [13,22].”
ResultInfluentialPrescribing Patterns for Treatment of Pediatric Bipolar Disorder in a Specialty Clinic
Potter, M. P., Liu, H. Y., Monuteaux, M. C., Henderson, C. S., Wozniak, J. R., Wilens, T. E., & Biederman, J. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2008.0142 · Cited by 38
“There is an emerging research base supporting the efficacy of multiple medications in pediatric bipolar disorder, with combined approaches targeting symptoms of mania and psychiatric co-morbidity (Kafantaris et al. 2001a; Kafantaris et al. 2001b; DelBello et al. 2002a; Delbello et al. 2002b; Findling et al. 2003; Kowa…”
Dopaminergic agents in the treatment of bipolar depression: a systematic review and meta-analysis
Szmulewicz, A. G., Angriman, F., Samamé, C., Ferraris, A., Vigo, D., & Strejilevich, S. A. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12712 · Cited by 37
Ludolph, A. G., Udvardi, P. T., Föhr, K. J., Henes, C., Liebau, S., Dreyhaupt, J., & Boeckers (2013) · Drug Design Development and Therapy · doi:10.2147/dddt.s50448 · Cited by 45
“Recently, two open-label studies with the NMDA antagonist memantine (20 mg/ day) in pediatric and adult ADHD patients showed positive effects on clinical symptoms.(68) Earlier studies pointed out the pivotal role of the NR2B subunit in neuron excitability and synaptic plasticity.”
The use of stimulants and atomoxetine in adults with comorbid ADHD and bipolar disorder
Perugi, G., & Vannucchi, G. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1079620 · Cited by 41
“This level of evidence was based on three controlled studies, two performed in the pediatric ADHD-BD population and one in adults with BD [24,32,33].”
BackgroundMethodResultPerugi, G., Pallucchini, A., Rizzato, S., Pinzone, V., & Rossi, P. D. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1618270 · Cited by 43
Use of adjunctive stimulants in adult bipolar depression
Dell'Osso, B., & Ketter, T. A. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000326 · Cited by 31
“Furthermore, other studies have reported safe and effective use of stimulants in paediatric bipolar subjects with comorbid ADHDwith or without concomitant therapy with mood stabilizers (Cicero et al. 2003; Findling et al. 2007; Scheffer et al. 2005).”
BackgroundBennett, F., Hodgetts, S., Close, A. J., Frye, M. A., Grunze, H., Keck, P. E., Kupka, R., McElroy, S. L., Nolen, W. A., Post, R. M., et al. (2019) · International Journal of Bipolar Disorders · doi:10.1186/s40345-019-0169-5 · Cited by 32
The Comorbidity of ADHD and Bipolar Disorder: Any Less Confusion?
Pataki, C. S., & Carlson, G. A. (2013) · Current Psychiatry Reports · doi:10.1007/s11920-013-0372-5 · Cited by 33
“Three placebo-controlled randomized trials evaluated the efficacy of stimulants for children with comorbid ADHD and bipolar disorder, one using methylphenidate in children after mood stabilization [70], another using methylphenidate in conjunction with aripiprazole, compared to placebo, and aripiprazole alone [71] , a…”
BackgroundResultGuerdjikova, A. I., & McElroy, S. L. (2013) · Europe PMC (PubMed Central) · Cited by 27
Issues in the Management of Patients with Complex Attention-Deficit Hyperactivity Disorder Symptoms
Spencer, T. J. (2009) · CNS Drugs · doi:10.2165/00023210-200923000-00003 · Cited by 21
Treating the Childhood Bipolar Controversy: A Tale of Two Children
Carlson, G. A. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08091362 · Cited by 24
Stevens, J. R., George, R. A., Fusillo, S. J., Stern, T. A., & Wilens, T. E. (2010) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2008.0128 · Cited by 22
“Combined medication regimens for youth with ADHD are often employed for co-morbid psychopathology (Tourette’s Syndrome Study Group 2002; Findling et al. 2007; Palumbo et al. 2008), as well as for the treatment of stimulant-induced adverse effects (Wi-lens et al. 1995).”
Mucci, F., Avella, M. T., & Marazziti, D. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190805153610 · Cited by 22
Clinical Manual of Child and Adolescent Psychopharmacology
(2017) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615371266 · Cited by 21
Baweja, R. K., & Waxmonsky, J. G. (2022) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2022.02.003 · Cited by 22
Pediatric Bipolar Disorder: Challenges in Diagnosis and Treatment
Wozniak, J. R., O’Connor, H., Iorini, M., & Ambrose, A. J. H. (2024) · Pediatric Drugs · doi:10.1007/s40272-024-00669-z · Cited by 24
Arousal Regulation in Affective Disorders
Hegerl, U., Sander, C., & Hensch, T. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802456-0.00012-1 · Cited by 20
Interventions for Youth at High Risk for Bipolar Disorder and Schizophrenia
McNamara, R. K., Strawn, J. R., Chang, K., & DelBello, M. P. (2012) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2012.07.009 · Cited by 18
A framework to avoid irrational polypharmacy in psychiatry
Zigman, D., & Blier, P. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112453211 · Cited by 16
“In contrast, stimulants did improve ADHD symptoms in youths with BD taking lithium and valproate (Findling et al., 2007; Scheffer et al., 2005).”
BackgroundSeok, J., Vaughan, B. S., Lew, B. J., Ahmad, A., Blair, J., & Hwang, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-33979-2 · Cited by 20
Miskowiak, K. W., Obel, Z. K., Guglielmo, R., Bonnín, C. D. M., Bowie, C. R., Balanzá‐Martínez, V., Burdick, K. E., Carvalho, A. F., Dols, A., Douglas, K. M., et al. (2024) · Bipolar Disorders · doi:10.1111/bdi.13414 · Cited by 22
“%) of methylphenidate or amphetamine salt treatment in pediatric or adolescent populations with BD. 57,58,60 We therefore consider add-on of these ADHD medications to mood stabilizers as a viable option for BD patients with comorbid ADHD symptoms based on their beneficial effects on ADHD symptoms,…”
BackgroundInfluentialLifetime evolution of ADHD treatment
Mucci, F., Carpita, B., Pagni, G., Vecchia, A. D., Bjedov, S., Pozza, A., & Marazziti, D. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02336-w · Cited by 18
Pharmacotherapy of ADHD in adults
Prince, J. B., Morrison, N. R., & Wilens, T. E. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139035491.023 · Cited by 14
Pouchon, A., Nasserdine, R., Dondé, C., Bertrand, A., Polosan, M., & Bioulac, S. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2224920 · Cited by 12
“[36], and a brief enough follow-up period to detect differences in adverse events between therapeutic agents.”
BackgroundManagement of Bipolar Disorder in Children and Adolescents
Patino, L. R., Bruns, K. M., Witt, N. M., McCune, N. R., & DelBello, M. P. (2015) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.130121 · Cited by 11
Treatment of Attention-Deficit/Hyperactivity Disorder
Pierce, K. (2011) · Pediatric Annals · doi:10.3928/00904481-20111007-06 · Cited by 12
MEYER, S. E., & Carlson, G. A. (2008) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.6.3.foc271 · Cited by 12
Risk of Mania After Methylphenidate in Patients With Bipolar Disorder
Jefsen, O. H., Østergaard, S. D., & Rohde, C. (2022) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001631 · Cited by 10
Stimulants in Bipolar Disorder: Beyond Common Beliefs
Hensch, T., Himmerich, H., Hegerl, U., & McIntyre, R. S. (2010) · CNS Spectrums · doi:10.1017/s1092852900000390 · Cited by 9
Chiorean, A., Jones, B. D. M., Murong, M., Gonzalez‐Torres, C., Kloiber, S. M., Ortiz, A., Rosenblat, J. D., Mulsant, B. H., & Husain, M. I. (2024) · Bipolar Disorders · doi:10.1111/bdi.13440 · Cited by 11
Treatment Implications for ADHD Youth with Mood and Anxiety Comorbidity
Baweja, R. K., & Waxmonsky, J. G. (2018) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-018-0135-3 · Cited by 11
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
Storebø, O. J., Storm, M. R. O., Ribeiro, J. P., Skoog, M., Groth, C., Edemann-Callesen, H., Schaug, J. P., Darling, P. J., Huus, C.-M. L., Zwi, M., et al. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009885.pub4 · Cited by 14
Drug Class Review: Pharmacologic Treatments for Attention Deficit Hyperactivity Disorder
McDonagh, M. S., & Peterson, K. (2011) · Cited by 7
Amerio, A., Arduino, G., Fesce, F., Costanza, A., Aguglia, A., Amore, M., & Serafini, G. (2024) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2024.2386429 · Cited by 7
“Regarding the treatment of comorbid ADHD, positive results have been reported in three clinical trials, although with modest-sized samples, using mixed amphetamine salts and methylphenidate combined with aripiprazole or divalproex, particularly in euthymic youth [114–116].”
Treatment of Children with Severe Mood Dysregulation
Waxmonsky, J. G., & Pariseau, M. E. (2009) · Child and Adolescent Psychopharmacology News · doi:10.1521/capn.2009.14.6.7 · Cited by 5
Irritability, Anger, and Aggression in the Context of Pediatric Bipolar Disorder
Patino, L. R., & DelBello, M. P. (2021) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2021.04.007 · Cited by 7
O’Connor, H., Vater, C. H., DiSalvo, M., Faraone, S. V., & Wozniak, J. R. (2023) · Journal of Attention Disorders · doi:10.1177/10870547231218045 · Cited by 5
“All of these samples were predominantly male: 75% (Findling et al., 2007), 64.3% (Zeni et al., 2009), 71% (Brikell et al., 2021), 86.9% (Madjar et al., 2019), 80.4% (Galanter et al., 2003), 65.9% (Faedda et al., 2004), 73.5% (DelBello et al., 2001), 63.5% (Soutullo et al., 2002), 73% (Wigal et al.,…”
BackgroundMethodInfluentialUpdate on pediatric bipolar disorder
Townsend, L. D., Demeter, C., Wilson, M., & Findling, R. L. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0072-0 · Cited by 5
“Findling et al. [ 42 ] found that methylphenidate in conjunction with mood stabilizers significantly improved ADHD symptoms while maintaining remission of affective symptoms.”
BackgroundSelf-citationMethylphenidate in Attention Deficit Hyperactivity Disorder and Bipolar Disorder
Kümmer, A., & Teixeira, A. L. (2008) · Australasian Psychiatry · doi:10.1177/000486740801600602 · Cited by 5
Evidence-based Strategies in Herbal Medicine, Psychiatric Disorders and Emergency Medicine
Badria, F. A.-E. (2015) · InTech eBooks · doi:10.5772/58511 · Cited by 5
Bipolar Disorder Among Children and Adolescents
Carlson, G. A., & Pataki, C. S. (2016) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20150038 · Cited by 4
Marcelli, D. (2009) · Encyclopédie médico-chirurgicale. Psychiatrie · doi:10.1016/s0246-1072(09)52367-x · Cited by 6
Armstrong, C., & Kapolowicz, M. R. (2021) · Military Medicine · doi:10.1093/milmed/usab305 · Cited by 4
Comorbidity in pediatric bipolar disorder: An unmet challenge in need of treatment studies
Goldstein, B. I. (2023) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13591 · Cited by 5
“A handful of studies regarding adjunctive treatment of comorbid ADHD with psychostimulants suggest that this approach is efficacious and relatively well tolerated.(15) 108 INVITED EDITORIAL”
BackgroundThe Treatment of Adult ADHD: Complexity at Hand
Pallanti, S., & Salerno, L. (2020) · Springer eBooks · doi:10.1007/978-3-030-39051-8_19 · Cited by 4
Wozniak, J. R., DiSalvo, M., Farrell, A., Yule, A. M., Joshi, G., Cook, E., Faraone, S. V., & Biederman, J. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221087673 · Cited by 4
“Due to the high rate of comorbid ADHD in pediatric populations with BPD, ranging from 60% to 90%, there is a small evidence base that supports the practice of using psychostimulants in bipolar populations, including two controlled clinical trials in youth with bipolar disorder (Findling et al., 2007; Scheffer et al.,…”
BackgroundKümmer, A., & Teixeira, A. L. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01176.x · Cited by 3
Practical Guide to ADHD Pharmacotherapy
Daughton, J., Liu, H. Y., West, M., Swanson, D. A., & Kratochvil, C. J. (2010) · Psychiatric Annals · doi:10.3928/00485713-20100330-03 · Cited by 3
Practice Pearls for Stimulant Treatment of Attention-Deficit/Hyperactivity Disorder in Youth.
Stutzman, D. L., & Dopheide, J. A. (2024) · PubMed Central · doi:10.5863/1551-6776-29.3.215 · Cited by 7
Adult ADHD in Bipolar and Related Disorders
Pallanti, S., & Salerno, L. (2020) · Springer eBooks · doi:10.1007/978-3-030-39051-8_9 · Cited by 2
Bipolar disorder and ADHD: Comorbidity throughout the life cycle
Joshi, G., & Wozniak, J. R. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139035491.008 · Cited by 4
Treatment of childhood-onset bipolar disorder
Findling, R. L. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8567-5_14 · Cited by 2
Self-citationRational Polypharmacy in Psychiatry
Nizamie, S. H., & Tikka, S. K. (2015) · InTech eBooks · doi:10.5772/59004 · Cited by 2
Bipolar Disorder in 10–17 Year Old Patients: Treatment Options and Cautions
Romero, P. A. A. S. (2011) · Clinical Medicine Reviews in Therapeutics · doi:10.4137/cmrt.s3084 · Cited by 1
Combination Pharmacotherapy for Psychiatric Disorders in Children and Adolescents
Joshi, G., & Georgiopoulos, A. M. (2012) · Wiley eBooks · doi:10.1002/9781119958338.ch17 · Cited by 1
Treatment of Childhood-Onset Bipolar Disorder
Kaplin, D. B., & Findling, R. L. (2016) · Milestones in drug therapy · doi:10.1007/978-3-319-31689-5_14 · Cited by 1
Self-citationBoumendjel, M. D. (2014) · HAL · Cited by 1
Attention-deficit hyperactivity disorder in bipolar disorder
Rydén, E. (2010) · Figshare
Prescribing Patterns for Treatment of Pediatric Bipolar Disorder in a Korean Inpatient Sample
Kwon, O., Park, S., Lee, S., Kim, J., Shin, M., Yoo, H., Cho, S.-C., & Kim, B.-N. (2014) · Journal of korean Academy of Child and Adolescent Psychiatry · doi:10.5765/jkacap.2014.25.1.14
Concurrent ADHD and bipolar disorder: A 2009 perspective
Scheffer, R. E. (2009) · Current Attention Disorders Reports · doi:10.1007/s12618-009-0014-3
“Findling and colleagues [ 9 ] have reported benefi cial effects of methylphenidate compared with placebo when given to 16 patients whose mania was well treated.”
BackgroundStimulant medication in children and adolescents
Stevens, J. R., & Wilens, T. E. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139035491.021
Pharmacologic Treatment Options for Bipolar Disorder in Children and Adolescents
Stepanova, E. A., & Findling, R. L. (2017) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-017-0125-x
Self-citationPediatric Bipolar Disorders and ADHD
Diler, R. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-64251-2_8 · Cited by 1
Early pharmacological interventions in youth
Kaplin, D. B., Stepanova, E. A., Grant, B., Budimirovic, D. B., & Findling, R. L. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812347-8.00011-7
Self-citationMcElroy, S. L., Guerdjikova, A. I., & Romo‐Nava, F. (2024) · Cambridge University Press eBooks · doi:10.1017/9781108973922.014
Pharmacotherapy of Attention-Deficit Hyperactivity Disorder Across the Life Span
Wilens, T. E., Prince, J. B., Stone, M., Biederman, J., Uchida, M., & Surman, C. B. H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-11844-9.00055-2
Metadata
- Authors
- FINDLING, R. L., SHORT, E. J., McNAMARA, N. K., DEMETER, C. A., STANSBREY, R. J., GRACIOUS, B. L., WHIPKEY, R., MANOS, M. J., & CALABRESE, J. R.
- Affiliations
- Cleveland Clinic (US)
- Corresponding author
- FINDLING, ROBERT L.
- ORCID
- Venue
- Journal of the American Academy of Child & Adolescent Psychiatry
- Publisher
- Elsevier BV
- Published
- 2007-11
- Volume
- 46
- Issue
- 11
- Pages
- 1445-1453
- ISSN
- 0890-8567 (ISSN-L)
- OpenAlex
- W2069069376
- Cited by
- 120
- References
- 28
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 9 · 2023: 5 · 2022: 3 · 2021: 3 · 2020: 2 · 2019: 3 · 2018: 3 · 2017: 21 · 2016: 4 · 2015: 6 · 2014: 8 · 2013: 5 · 2012: 11
- FWCI
- 5.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Journal of the American Academy of Child & Adolescent Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- methylphenidate, bipolar disorder, attention deficit hyperactivity disorder, comorbidities, children and adolescents, ADHD Rating Scale-IV, stimulant medication, treatment efficacy, tolerability
- MeSH terms
- Adolescent, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Bipolar Disorder, Child, Child, Preschool, Double-Blind Method, Female, Humans, Male, Methylphenidate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.